Drugs / Carbon C 14 Oxaliplatin
Carbon C 14 Oxaliplatin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02569723 | Oct 2015 → Apr 2018 | colon adenocarcinoma | Edward Kim | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carbon C 14 Oxaliplatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02569723 ↗ |
| Modality | Diagnostic / imaging agent | “Microdose carbon C 14 oxaliplatin diagnostic assay” NCT02569723 ↗ |
| Route | Intravenous | “Intravenous infusion” NCT02569723 ↗ |